States Poised to Move Forward in Lowering Drug Costs
Drug Prices
States Poised to Move Forward in Lowering Drug Costs
Prescription for Higher Prices: The Real Cost of the EPIC Act
Drug Prices
Prescription for Higher Prices: The Real Cost of the EPIC Act
Reducing Federal Health Spending by Cutting Unnecessary Costs, Not Coverage
Drug Prices
Reducing Federal Health Spending by Cutting Unnecessary Costs, Not Coverage
Drug Costs and Their Impact on Care
Drug Prices
Drug Costs and Their Impact on Care
AV Proposals for Achieving Fiscally Responsible Tax Reform
Federal Tax Policy
AV Proposals for Achieving Fiscally Responsible Tax Reform
“Not a Fair and Open Market” John Arnold on Health Care Reform at Forbes 400 Philanthropy Summit
Drug Prices
“Not a Fair and Open Market” John Arnold on Health Care Reform at Forbes 400 Philanthropy Summit
How Do Patients and Providers Feel About Drug Costs in Medicare?
Drug Prices
How Do Patients and Providers Feel About Drug Costs in Medicare?
Medicare Sustainability
Enhancing Transparency in Medicare Advantage Data
Meaningful Reforms to Medicare Are Needed Now to Sustain the Program for Future Generations
Medicare Sustainability
Meaningful Reforms to Medicare Are Needed Now to Sustain the Program for Future Generations
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan
Drug Prices
AV Recommends More Clear Disclosures for Medicare Prescription Payment Plan
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Drug Prices
Colorado Prescription Drug Affordability Board says: Pharma, the Price is Wrong
Medicare Sustainability
AV Submits Letter Addressing Overpayments in Medicare Advantage
Drug Prices
What a Bipartisan State of the Union Looks Like
Op-Ed
Medicare-Medicaid Integration
AV Submits Letter on Transparency and Accountability in Medicare Advantage
A Year in Policy Wins
Drug Prices
A Year in Policy Wins
23 Stories of Transformative Policymaking from 2023
Policing
23 Stories of Transformative Policymaking from 2023
Year in Review
Drug Prices
AV Submits Letter on Excise Tax on Designated Drugs
In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment
Drug Prices
In Louisiana, a Subscription-Based Model Is Changing Hepatitis C Treatment
How a Broken Patent System Contributes to Unaffordable Prescription Drugs
Drug Prices
How a Broken Patent System Contributes to Unaffordable Prescription Drugs
Drug Prices
AV Submits Formal Comments for Proposed Rule on Drug Rebate Program
Drug Prices
How Policymakers Can Fix Pharmacy Benefit Managers
State by State, Lawmakers Aim at Affordable Prescriptions for All
Drug Prices
State by State, Lawmakers Aim at Affordable Prescriptions for All
3 Evidence-Based Reasons Medicare Negotiation Makes Sense
Drug Prices
3 Evidence-Based Reasons Medicare Negotiation Makes Sense
Landmark Drug Pricing Reforms Moving Forward
Drug Prices
Landmark Drug Pricing Reforms Moving Forward
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
